Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 2/20 | 0.32 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | PREP | P48147 | 2/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3799787 | 0.81 | BACE1 (0.42) | BACE1TACR1PREP | |
| SCHEMBL3796502 | 0.80 | IDO1 (0.39) | TACR1PREP | |
| SCHEMBL3978083 | 0.71 | BACE1 (0.38) | BACE1TACR1 | |
| SCHEMBL7134633 | 0.70 | BACE1 (0.43) | BACE1TACR1PREP | |
| SCHEMBL3408685 | 0.68 | IDO1 (0.53) | BACE1CARM1PRMT6 | |
| SCHEMBL2769611 | 0.68 | IDO1 (0.53) | BACE1 | |
| SCHEMBL7922813 | 0.68 | BACE1 (0.44) | BACE1TACR1PREP | |
| SCHEMBL21587953 | 0.68 | BACE1 (0.44) | BACE1 | |
| SCHEMBL3940682 | 0.68 | BACE1 (0.44) | BACE1 | |
| SCHEMBL6438766 | 0.68 | IDO1 (0.53) | BACE1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | CYCS, CHN2, TUBA3C | BACE1 4710/4885TACR1 3886/4885CARM1 1965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.